Results 181 to 190 of about 4,256 (218)

Plasmin-cleaved von Willebrand factor as a biomarker for microvascular thrombosis.

open access: yesBlood
El Otmani H   +7 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

The Preparation of Human Fibrinolysin (Plasmin)

Vox Sanguinis, 1960
SummaryTo date, methods reported for purifying human profibrinolysin have given erratic yields and purities. A versatile method is described for purification which can be used with most preparations of Fraction III from human plasma. This method results in a good yield of a highly purified profibrinolysin.
H. D. Anderson   +4 more
openaire   +3 more sources

Fibrinolysin Studies in Hemophilia

Archives of Internal Medicine, 1966
THE PURPOSE of this investigation was to determine whether inappropriate fibrinolysis may be detected in the blood of patients with classical, sex-linked hemophilia (hemophilia A, factor VIII deficiency). The occurrence of spontaneous, unprovoked hemorrhage in many of these patients, without an actual change in the level of factor VIII, 1 suggested ...
Lawrence H. Beizer   +3 more
openaire   +3 more sources

Fibrinolysin Treatment of Thromboembolism

JAMA, 1964
Fibrinolysin (Thrombolysin) has been used in various dosage schedules for thromboembolic disorders, but its clinical value has not been established. In this study, a single large intravenous dose was given at onset of anticoagulant therapy to 170 patients with thrombophlebitis, pulmonary embolism, or acute myocardial infarction.
George Ross Fisher   +3 more
openaire   +3 more sources

Influence of Fibrinolysin on Shock

JAMA, 1963
THE COMMON DENOMINATOR of all types of reversible shock appears to be an inadequate perfusion of vital visceral capillaries. This is affected, but not exclusively determined, by arterial blood pressure, cardiac output and venous return to the heart, vasoconstriction or dilitation, blood volume, heart failure, and other factors.
Dale G. Johnson, Robert M. Hardaway
openaire   +3 more sources

USE OF FIBRINOLYSIN IN SURGICAL COMPLICATIONS

Archives of Surgery, 1952
WE ARE presenting our experience with the enzymatic agent fibrinolysin in the treatment of several surgical complications. One hundred instances in which the material was used are reviewed in order to evaluate its worth. The proenzyme, profibrinolysin, occurs naturally and circulates in human and animal plasma.
R. R. Margulis, B. E. Brush
openaire   +3 more sources

TREATMENT OF THROMBOSIS WITH FIBRINOLYSIN (PLASMIN)

Journal of the American Medical Association, 1958
The possibility of dissolving a recent thrombus by the intravenous administration of a fibrinolytic enzyme was studied in a series of patients. Fibrinolysin (plasmin) was prepared in several ways from human and bovine plasma, and preparations were obtained from other laboratories also. Altogether 114 infusions of fibrinolysin were given to 37 volunteer
Julian L. Ambrus   +2 more
openaire   +3 more sources

Enzymatic débridement with bovine fibrinolysin

The American Journal of Surgery, 1959
Abstract Bovine fibrinolysin, alone or in combination with desoxyribonuclease, appears to be of value in the enzymatic debridement of ulcerating wounds. This agent achieved more rapid and frequently more effective superficial debridement of a significant proportion of ulcerating surfaces which had failed to respond satisfactorily to other forms of ...
E.F. Wolfman   +3 more
openaire   +4 more sources

Lability of Fibrinolysin

Nature, 1959
FEARNLEY'S method for estimating fibrinolytic activity of normal blood1 is based on the fact that the clot formed by adding thrombin to blood diluted 1 : 10 with phosphate buffer will lyse on incubation. This lytic activity may be lost if the specimen is permitted to stand for hours or even minutes at room temperature.
openaire   +2 more sources

Home - About - Disclaimer - Privacy